Form 8-K - Current report:
SEC Accession No. 0001493152-25-028156
Filing Date
2025-12-17
Accepted
2025-12-17 16:30:51
Documents
12
Period of Report
2025-12-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46440
  Complete submission text file 0001493152-25-028156.txt   211096

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aim-20251216.xsd EX-101.SCH 3014
3 XBRL LABEL FILE aim-20251216_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE aim-20251216_pre.xml EX-101.PRE 22359
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3566
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 251579707
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)